Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7905878 | 0.81 | SRD5A1 (0.55) | SRD5A2SRD5A1 | |
| SCHEMBL916468 | 0.73 | SRD5A1 (0.54) | SRD5A2SRD5A1 | |
| SCHEMBL8523823 | 0.69 | AR (0.38) | — | |
| SCHEMBL7903642 | 0.68 | SRD5A1 (0.54) | SRD5A2SRD5A1 | |
| SCHEMBL8996729 | 0.67 | SRD5A1 (0.34) | SRD5A2SRD5A1 | |
| SCHEMBL916288 | 0.67 | SRD5A1 (0.52) | SRD5A2SRD5A1 | |
| SCHEMBL915553 | 0.67 | SRD5A1 (0.53) | SRD5A2SRD5A1 | |
| SCHEMBL7903628 | 0.66 | — | — | |
| SCHEMBL8925171 | 0.65 | SRD5A1 (0.54) | SRD5A2SRD5A1 | |
| SCHEMBL17340861 | 0.65 | NR1I3 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0786999-A4 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO INC (US) | 1999-01-20 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| EP-0724592-A1 | 16-SUBSTITUTED-4-AZA-ANDROSTANE 5-ALPHA-REDUCTASE ISOZYME 1 INHIBITORS | MERCK & CO. INC. (US) | 1996-08-07 | — | — | EP | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1995011254-A1 | 16-SUBSTITUTED-4-AZA-ANDROSTANE 5-ALPHA-REDUCTASE ISOZYME 1 INHIBITORS | MERCK & CO., INC. (US) | 1995-04-27 | — | — | WO | claimed |